Trihydrophobin 1 phosphorylation by c-Src regulates MAPK/ERK signaling and cell migration

PLoS ONE

Volumn 7, Issue 1, 2012, Pages

  Wu, Weibin ^a   Sun, Zhichao ^a   Wu, Jingwen ^a   Peng, Xiaomin ^a   Gan, Huacheng ^a   Zhang, Chunyi ^a   Ji, Lingling ^a   Xie, Jianhui ^a   Zhu, Haiyan ^a   Ren, Shifang ^a   Gu, Jianxin ^a   Zhang, Songwen ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

A RAF KINASE; CELL PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; P21 ACTIVATED KINASE 1; PROTEIN KINASE P60; TRIHYDROPHOBIN 1; TYROSINE; UNCLASSIFIED DRUG; CARRIER PROTEIN; CSK TYROSINE PROTEIN KINASE; CSK TYROSINE-PROTEIN KINASE; PROTEIN TYROSINE KINASE; TH1L PROTEIN, HUMAN;

ARTICLE; CELL MIGRATION; CELL STIMULATION; CONTROLLED STUDY; ENZYME INHIBITION; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; ANIMAL; CELL MOTION; CELL STRAIN COS1; CELL STRAIN HEK293; CERCOPITHECUS; ENZYME ACTIVATION; GENETICS; HELA CELL; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; TUMOR CELL CULTURE;

ANIMALS; CARRIER PROTEINS; CELL MOVEMENT; CERCOPITHECUS AETHIOPS; COS CELLS; ENZYME ACTIVATION; HEK293 CELLS; HELA CELLS; HUMANS; MAP KINASE SIGNALING SYSTEM; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; TUMOR CELLS, CULTURED;

EID: 84855470323     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0029920     Document Type: Article

References (54)

1. Yeatman TJ, (2004) A renaissance for SRC. Nat Rev Cancer 4: 470-480.
2. Frame MC, (2002) Src in cancer: deregulation and consequences for cell behaviour. Biochim Biophys Acta 1602: 114-130.
3. Soriano P, Montgomery C, Geske R, Bradley A, (1991) Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 64: 693-702.
4. Ishizawar R, Parsons SJ, (2004) c-Src and cooperating partners in human cancer. Cancer Cell 6: 209-214.
5. Mayer EL, Krop IE, (2010) Advances in targeting SRC in the treatment of breast cancer and other solid malignancies. Clin Cancer Res 16: 3526-3532.
6. Chen J, (2008) Is Src the key to understanding metastasis and developing new treatments for colon cancer? Nat Clin Pract Gastroenterol Hepatol 5: 306-307.
7. Kim LC, Song L, Haura EB, (2009) Src kinases as therapeutic targets for cancer. Nat Rev Clin Oncol 6: 587-595.
8. Martin GS, (2001) The hunting of the Src. Nat Rev Mol Cell Biol 2: 467-475.
9. Irby RB, Yeatman TJ, (2000) Role of Src expression and activation in human cancer. Oncogene 19: 5636-5642.
10. Sicheri F, Kuriyan J, (1997) Structures of Src-family tyrosine kinases. Curr Opin Struct Biol 7: 777-785.
11. Cole PA, Shen K, Qiao Y, Wang D, (2003) Protein tyrosine kinases Src and Csk: a tail's tale. Curr Opin Chem Biol 7: 580-585.
12. Bjorge JD, Jakymiw A, Fujita DJ, (2000) Selected glimpses into the activation and function of Src kinase. Oncogene 19: 5620-5635.
13. Sun G, Sharma AK, Budde RJ, (1998) Autophosphorylation of Src and Yes blocks their inactivation by Csk phosphorylation. Oncogene 17: 1587-1595.
14. Chong YP, Ia KK, Mulhern TD, Cheng HC, (2005) Endogenous and synthetic inhibitors of the Src-family protein tyrosine kinases. Biochim Biophys Acta 1754: 210-220.
15. Banga SS, Yamamoto AH, Mason JM, Boyd JB, (1995) Molecular cloning of mei-41, a gene that influences both somatic and germline chromosome metabolism of Drosophila melanogaster. Mol Gen Genet 246: 148-155.
16. Hari KL, Santerre A, Sekelsky JJ, McKim KS, Boyd JB, et al. (1995) The mei-41 gene of D. melanogaster is a structural and functional homolog of the human ataxia telangiectasia gene. Cell 82: 815-821.
17. Bonthron DT, Hayward BE, Moran V, Strain L, (2000) Characterization of TH1 and CTSZ, two non-imprinted genes downstream of GNAS1 in chromosome 20q13. Hum Genet 107: 165-175.
18. Narita T, Yamaguchi Y, Yano K, Sugimoto S, Chanarat S, et al. (2003) Human transcription elongation factor NELF: identification of novel subunits and reconstitution of the functionally active complex. Mol Cell Biol 23: 1863-1873.
19. Wu CH, Yamaguchi Y, Benjamin LR, Horvat-Gordon M, Washinsky J, et al. (2003) NELF and DSIF cause promoter proximal pausing on the hsp70 promoter in Drosophila. Genes Dev 17: 1402-1414.
20. Aiyar SE, Sun JL, Blair AL, Moskaluk CA, Lu YZ, et al. (2004) Attenuation of estrogen receptor alpha-mediated transcription through estrogen-stimulated recruitment of a negative elongation factor. Genes Dev 18: 2134-2146.
21. Cheng C, Kong X, Wang H, Gan H, Hao Y, et al. (2009) Trihydrophobin 1 Interacts with PAK1 and Regulates ERK/MAPK Activation and Cell Migration. J Biol Chem 284: 8786-8796.
22. Liu W, Shen X, Yang Y, Yin X, Xie J, et al. (2004) Trihydrophobin 1 is a new negative regulator of A-Raf kinase. J Biol Chem 279: 10167-10175.
23. Yin XL, Chen S, Gu JX, (2002) Identification of TH1 as an interaction partner of A-Raf kinase. Mol Cell Biochem 231: 69-74.
24. Zou W, Yang Y, Wu Y, Sun L, Chi Y, et al. (2010) Negative role of trihydrophobin 1 in breast cancer growth and migration. Cancer Sci 101: 2156-2162.
25. Chen Y, Long H, Wu Z, Jiang X, Ma L, (2008) EGF transregulates opioid receptors through EGFR-mediated GRK2 phosphorylation and activation. Mol Biol Cell 19: 2973-2983.
26. Fincham VJ, Frame MC, (1998) The catalytic activity of Src is dispensable for translocation to focal adhesions but controls the turnover of these structures during cell motility. Embo J 17: 81-92.
27. Fincham VJ, Unlu M, Brunton VG, Pitts JD, Wyke JA, et al. (1996) Translocation of Src kinase to the cell periphery is mediated by the actin cytoskeleton under the control of the Rho family of small G proteins. J Cell Biol 135: 1551-1564.
28. Huveneers S, Danen EH, (2009) Adhesion signaling- crosstalk between integrins, Src and Rho. J Cell Sci 122: 1059-1069.
29. Webb DJ, Donais K, Whitmore LA, Thomas SM, Turner CE, et al. (2004) FAK-Src signalling through paxillin, ERK and MLCK regulates adhesion disassembly. Nat Cell Biol 6: 154-161.
30. Fincham VJ, James M, Frame MC, Winder SJ, (2000) Active ERK/MAP kinase is targeted to newly forming cell-matrix adhesions by integrin engagement and v-Src. Embo J 19: 2911-2923.
31. Vial E, Sahai E, Marshall CJ, (2003) ERK-MAPK signaling coordinately regulates activity of Rac1 and RhoA for tumor cell motility. Cancer Cell 4: 67-79.
32. Bellis SL, Miller JT, Turner CE, (1995) Characterization of tyrosine phosphorylation of paxillin in vitro by focal adhesion kinase. J Biol Chem 270: 17437-17441.
33. Webb DJ, Parsons JT, Horwitz AF, (2002) Adhesion assembly, disassembly and turnover in migrating cells - over and over and over again. Nat Cell Biol 4: E97-100.
34. Bromann PA, Korkaya H, Courtneidge SA, (2004) The interplay between Src family kinases and receptor tyrosine kinases. Oncogene 23: 7957-7968.
35. Migliaccio A, Di Domenico M, Castoria G, de Falco A, Bontempo P, et al. (1996) Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. Embo J 15: 1292-1300.
36. Playford MP, Schaller MD, (2004) The interplay between Src and integrins in normal and tumor biology. Oncogene 23: 7928-7946.
37. Avizienyte E, Frame MC, (2005) Src and FAK signalling controls adhesion fate and the epithelial-to-mesenchymal transition. Curr Opin Cell Biol 17: 542-547.
38. Schlaepfer DD, Hauck CR, Sieg DJ, (1999) Signaling through focal adhesion kinase. Prog Biophys Mol Biol 71: 435-478.
39. Melillo RM, Barone MV, Lupoli G, Cirafici AM, Carlomagno F, et al. (1999) Ret-mediated mitogenesis requires Src kinase activity. Cancer Res 59: 1120-1126.
40. Wong BR, Besser D, Kim N, Arron JR, Vologodskaia M, et al. (1999) TRANCE, a TNF family member, activates Akt/PKB through a signaling complex involving TRAF6 and c-Src. Mol Cell 4: 1041-1049.
41. Abu-Ghazaleh R, Kabir J, Jia H, Lobo M, Zachary I, (2001) Src mediates stimulation by vascular endothelial growth factor of the phosphorylation of focal adhesion kinase at tyrosine 861, and migration and anti-apoptosis in endothelial cells. Biochem J 360: 255-264.
42. Holzer RG, Park EJ, Li N, Tran H, Chen M, et al. (2011) Saturated fatty acids induce c-Src clustering within membrane subdomains, leading to JNK activation. Cell 147: 173-184.
43. Kodama H, Fukuda K, Takahashi E, Tahara S, Tomita Y, et al. (2003) Selective involvement of p130Cas/Crk/Pyk2/c-Src in endothelin-1-induced JNK activation. Hypertension 41: 1372-1379.
44. Lauffenburger DA, Horwitz AF, (1996) Cell migration: a physically integrated molecular process. Cell 84: 359-369.
45. Cary LA, Han DC, Polte TR, Hanks SK, Guan JL, (1998) Identification of p130Cas as a mediator of focal adhesion kinase-promoted cell migration. J Cell Biol 140: 211-221.
46. Klemke RL, Cai S, Giannini AL, Gallagher PJ, de Lanerolle P, et al. (1997) Regulation of cell motility by mitogen-activated protein kinase. J Cell Biol 137: 481-492.
47. Yu CF, Liu ZX, Cantley LG, (2002) ERK negatively regulates the epidermal growth factor-mediated interaction of Gab1 and the phosphatidylinositol 3-kinase. J Biol Chem 277: 19382-19388.
48. Hunger-Glaser I, Salazar EP, Sinnett-Smith J, Rozengurt E, (2003) Bombesin, lysophosphatidic acid, and epidermal growth factor rapidly stimulate focal adhesion kinase phosphorylation at Ser-910: requirement for ERK activation. J Biol Chem 278: 22631-22643.
49. Glading A, Bodnar RJ, Reynolds IJ, Shiraha H, Satish L, et al. (2004) Epidermal growth factor activates m-calpain (calpain II), at least in part, by extracellular signal-regulated kinase-mediated phosphorylation. Mol Cell Biol 24: 2499-2512.
50. Carragher NO, Westhoff MA, Fincham VJ, Schaller MD, Frame MC, (2003) A novel role for FAK as a protease-targeting adaptor protein: regulation by p42 ERK and Src. Curr Biol 13: 1442-1450.
51. Huang C, Jacobson K, Schaller MD, (2004) MAP kinases and cell migration. J Cell Sci 117: 4619-4628.
52. Chu I, Sun J, Arnaout A, Kahn H, Hanna W, et al. (2007) p27 phosphorylation by Src regulates inhibition of cyclin E-Cdk2. Cell 128: 281-294.
53. Yamaguchi Y, Takagi T, Wada T, Yano K, Furuya A, et al. (1999) NELF, a multisubunit complex containing RD, cooperates with DSIF to repress RNA polymerase II elongation. Cell 97: 41-51.
54. Penela P, Elorza A, Sarnago S, Mayor F Jr, (2001) Beta-arrestin- and c-Src-dependent degradation of G-protein-coupled receptor kinase 2. Embo J 20: 5129-5138.